NCT05892744View on ClinicalTrials.gov

Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

July 15, 2027

Study Completion Date

July 15, 2027

Conditions
Major Depressive DisorderChronic Major Depression, Recurrent
Interventions
DRUG

Sertraline

50-200mg/day

Trial Locations (1)

78712

RECRUITING

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin

All Listed Sponsors
collaborator

Lehigh University

OTHER

lead

University of Texas at Austin

OTHER